Robert Langer, Director at Rubius Therapeutics, Inc. (RUBY), sold 7,500 shares at $14.59 ($109K) on 2019-01-14, disclosed to the SEC on 2019-01-18.
Open-market sale of $109k RUBY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RUBY | SELL | 2019-04-17 | $132K | — | Filing → |
| NVIV | SELL | 2013-06-05 | $28K | — | Filing → |
| NVIV | SELL | 2013-05-31 | $25K | — | Filing → |